Profile data is unavailable for this security.
About the company
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.
- Revenue in USD (TTM)21.84bn
- Net income in USD2.81bn
- Incorporated1995
- Employees62.26k
- LocationMerck KGaAFrankfurter Strasse 250DARMSTADT 64293GermanyDEU
- Phone+49 6151720
- Fax+49 6 151722000
- Websitehttps://www.merckgroup.com/
Mergers & acquisitions
| Acquired company | MRKX:GER since announced | Transaction value |
|---|---|---|
| Unity Semiconductor SAS | -7.51% | 169.52m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharmaceutical Co Ltd | 29.38bn | 1.87bn | 42.28bn | 49.28k | 22.61 | 0.9421 | 6.24 | 1.44 | 181.90 | 181.90 | 2,862.68 | 4,365.91 | 0.3088 | 1.31 | 6.25 | 92,248,190.00 | 1.97 | 1.65 | 2.35 | 1.97 | 66.05 | 68.05 | 6.38 | 6.06 | 0.7739 | 3.08 | 0.4219 | 128.42 | 5.87 | 15.25 | -54.56 | 1.28 | 29.09 | 0.8735 |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 3.59bn | 751.92m | 42.50bn | 19.61k | 56.80 | 7.04 | -- | 11.84 | 0.8499 | 0.8499 | 4.06 | 6.86 | 0.57 | 1.57 | 4.60 | 1,325,555.00 | 11.94 | 13.68 | 12.99 | 15.20 | 84.88 | 85.87 | 20.94 | 20.01 | 8.34 | -- | 0.002 | 23.77 | 7.26 | 5.55 | 10.14 | 1.14 | 22.90 | 9.45 |
| Haleon PLC | 14.09bn | 1.51bn | 43.15bn | 24.00k | 28.90 | -- | 183.14 | 3.06 | 0.1316 | 0.1316 | 1.22 | -- | -- | -- | -- | 468,333.30 | -- | -- | -- | -- | 61.94 | -- | 11.21 | -- | -- | 7.59 | -- | -- | 4.09 | -- | -1.04 | -- | -- | -- |
| Sun Pharmaceutical Industries Ltd | 5.96bn | 1.31bn | 51.02bn | 43.00k | 38.93 | 6.23 | 31.46 | 8.56 | 46.12 | 46.12 | 209.89 | 288.06 | 0.6005 | 1.05 | 4.15 | 11,699,470.00 | 13.29 | 7.77 | 16.92 | 10.85 | 79.15 | 71.59 | 22.14 | 14.23 | 2.09 | -- | 0.0358 | 38.64 | 10.51 | 10.78 | 13.01 | 29.15 | -7.28 | 37.47 |
| Daiichi Sankyo Co Ltd | 11.36bn | 1.62bn | 55.80bn | 18.73k | 33.89 | 5.18 | 27.41 | 4.91 | 130.86 | 130.86 | 918.60 | 855.86 | 0.5913 | 1.01 | 3.73 | 93,883,960.00 | 8.43 | 4.99 | 10.51 | 6.14 | 76.11 | 69.10 | 14.26 | 9.94 | 2.24 | -- | 0.0589 | 51.87 | 25.28 | 11.49 | 85.90 | 16.67 | 13.01 | 16.47 |
| Merck KGaA (ADR) | 21.84bn | 2.81bn | 64.54bn | 62.26k | 22.84 | -- | 13.69 | 2.96 | 1.29 | 1.29 | 10.05 | -- | 0.4191 | 1.85 | 4.98 | 347,128.20 | 5.41 | 5.64 | 6.70 | 7.27 | 58.60 | 61.86 | 12.90 | 12.97 | 0.9103 | 54.78 | 0.2861 | 9.26 | -5.57 | 7.19 | -15.09 | 21.40 | 14.77 | -- |
| Chugai Pharmaceutical Co Ltd | 7.38bn | 2.50bn | 68.03bn | 7.60k | 26.66 | 5.73 | -- | 9.22 | 235.14 | 235.14 | 694.16 | 1,094.71 | 0.5877 | 1.22 | 3.56 | 150,230,100.00 | 19.91 | 19.29 | 22.95 | 23.91 | 70.48 | 63.57 | 33.87 | 28.39 | 4.80 | -- | 0.00 | 40.14 | -11.78 | 13.90 | -13.08 | 28.61 | -0.8947 | 27.23 |
| GSK plc | 39.24bn | 3.15bn | 69.71bn | 70.21k | 22.03 | 3.91 | 9.92 | 1.78 | 0.6093 | 0.6093 | 7.62 | 3.43 | 0.5266 | 1.51 | 3.93 | 445,949.40 | 4.79 | 6.74 | 7.48 | 10.71 | 72.44 | 70.29 | 9.10 | 16.93 | 0.5303 | 13.08 | 0.5442 | 79.55 | 3.42 | -0.322 | 15.79 | 7.10 | 5.47 | -10.32 |
| Zoetis Inc | 9.15bn | 2.43bn | 79.84bn | 14.10k | 33.27 | 15.27 | 27.17 | 8.72 | 5.32 | 5.32 | 20.02 | 11.59 | 0.6431 | 1.06 | 6.86 | 649,078.00 | 17.13 | 14.47 | 19.38 | 17.18 | 70.13 | 69.77 | 26.64 | 25.77 | 2.27 | 18.96 | 0.5567 | 26.89 | 5.74 | 7.96 | 10.88 | 11.13 | 16.71 | 24.37 |
| CSL Ltd | 14.78bn | 2.64bn | 87.03bn | 30.40k | 33.05 | 5.01 | 23.87 | 5.89 | 8.36 | 8.36 | 46.85 | 55.18 | 0.3986 | 1.25 | 5.80 | 747,770.50 | 7.31 | 9.46 | 8.95 | 11.70 | 51.83 | 53.84 | 18.34 | 20.11 | 0.9705 | 8.74 | 0.3857 | 46.70 | 11.19 | 11.63 | 20.42 | 6.61 | -0.4207 | 7.26 |
| Holder | Shares | % Held |
|---|---|---|
| Henry James International Management, Inc.as of 30 Sep 2024 | 70.21k | 0.01% |
| Domini Impact Investments LLCas of 31 Jul 2024 | 22.60k | 0.00% |
| RhumbLine Advisers LPas of 30 Sep 2024 | 11.46k | 0.00% |
| Yousif Capital Management LLCas of 30 Sep 2024 | 10.02k | 0.00% |
| Causeway Capital Management LLCas of 07 Nov 2024 | 5.38k | 0.00% |
| GAMMA Investing LLCas of 30 Sep 2024 | 1.85k | 0.00% |
| ShariaPortfolio, Inc.as of 07 Nov 2024 | 1.51k | 0.00% |
| PNC Investments LLCas of 30 Sep 2024 | 297.00 | 0.00% |
| First Horizon Advisors, Inc.as of 30 Sep 2024 | 60.00 | 0.00% |
| Manulife Investment Management Ltd.as of 30 Jun 2024 | 0.00 | 0.00% |
